产品介绍
Product Description
Biochem/physiol Actions
Glucosylceramide synthase inhibitor, used for treatment of type 1 Gaucher disease
Eliglustat is a potent and selctive glucosylceramide synthase inhibitor approved for treatment of type 1 Gaucher disease.
技术参数
Specifications
| Quality Segment | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | −20°C |
| SMILES string | N3(CCCC3)C[C@@H](NC(=O)CCCCCCC)[C@H](O)c1cc2c(cc1)OCCO2 |
| InChI | 1S/C23H36N2O4/c1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20/h10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26)/t19-,23-/m1/s1 |
| InChI key | FJZZPCZKBUKGGU-AUSIDOKSSA-N |
